Table 2.
Top SNP from the GWAS for pCR, DFS, OS, and bevacizumab-treated patients with replication utilizing GeparQuinto
| B40 | GeparQuinto | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| rsID | CHR | POS | CA | MA | N | MAF | OR | lci | uci | pvalue | N | MAF | OR | lci | uci | Pvalue | |
| pCR | rs34843881 | 13 | 25971560 | C | T | 914 | 0.096 | 2.899 | 1.940 | 4.331 | 2.04E−07 | 1398 | 0.095 | 0.937 | 0.650 | 1.352 | 0.73 |
| DFS | rs78269823 | 14 | 39264849 | C | T | 890 | 0.067 | 0.197 | 0.093 | 0.416 | 5.61E−08 | 1398 | 0.117 | 0.952 | 0.688 | 1.316 | 0.76 |
| OS | rs56330643 | 14 | 100388910 | A | G | 891 | 0.297 | 2.050 | 1.588 | 2.645 | 5.63E−08 | 1398 | 0.357 | 0.926 | 0.738 | 1.161 | 0.50 |
| Bev, pCR | rs7453577 | 6 | 20987675 | G | A | 447 | 0.203 | 2.734 | 1.861 | 4.016 | 2.97E−07 | 733 | 0.209 | 1.498 | 1.029 | 2.182 | 0.04 |
rsID: reference sequence ID,